obesity drugs glp-1 news today Study predicts 16 new may come to market FDA says that the GLP-1

Muscle loss slows resting metabolism, increases the risk of weight regain after stopping, and in older patients, significantly impacts physical function and fall risk

Switching between GLP-1 medications rarely resolves fatigue because the cause is caloric deficit, not a specific drug

Chen, L

The healthcare system is already stretched thin, with many Medicare beneficiaries facing long waits for appointments with doctors, said Dr

Cunnane, A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment, Alzheimer's & Dementia, Volume 15, Issue 5, 2019, Pages 625-634, ISSN 1552-5260, Cunnane SC, Courchesne-Loyer A, Vandenberghe C, St-Pierre V, Fortier M, Hennebelle M, Croteau E, Bocti C, Fulop T, Castellano CA